Literature DB >> 6244072

Carcinoma of major salivary glands.

H Shidnia, N B Hornback, R Hamaker, R Lingeman.   

Abstract

Ninety-four patients with carcinoma of the major salivary glands seen at Indiana University Hospitals from 1960-1977 were studied. Eighty-four patients completed their planned course of therapy, and 49 of 84 patients remain alive with no evidence of disease 2-17 years following treatment. Comparison has been made for three modalities: surgery alone, radiation therapy alone, and a combined approach. Surgery alone was used for treatment of early lesions, and 22 of 38 patients (58%) remain free of disease. Radiation therapy alone was used for advanced cases and palliation, and 6 of 16 patients (37.5%) remain free of disease. In the combination treatment, 21 of 30 patients (70%) are alive and free of disease. In the combination treatment, 21 of 30 patients (70%) are alive and free of disease from 2-17 years after treatment. Ten patients did not complete treatment and all of these patients died of disease.

Entities:  

Mesh:

Year:  1980        PMID: 6244072     DOI: 10.1002/1097-0142(19800215)45:4<693::aid-cncr2820450413>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review.

Authors:  Nolan B Seim; Ramez H W Philips; Lynn Schoenfield; Theodoros N Teknos; James W Rocco; Amit Agrawal; Enver Ozer; Ricardo L Carrau; Stephen Y Kang; Matthew O Old
Journal:  Head Neck Pathol       Date:  2017-03-27

2.  Carcinoma of the major salivary glands.

Authors:  S E Afify; J D Maynard
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

3.  Radiotherapy for parotid cancer.

Authors:  L M Toonkel; S Guha; P Foster; V Dembrow
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

4.  The Role of Postoperative Radiotherapy and Prognostic Model in Primary Squamous Cell Carcinoma of Parotid Gland.

Authors:  Wenlong Qiu; Yong Yang; Shiran Sun; Fengge Zhou; Yi Xu; Xi Luo; Zekun Wang; Meilin He; Yang Liu; Junlin Yi
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 6.244

5.  A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands.

Authors:  A S Jones; D E Phillips; J A Cook; T R Helliwell
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

6.  The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.

Authors:  Shu-Ming Liu; Hai-Bo Wang; Yan Sun; Yan Shi; Jie Zhang; Ming-Wei Huang; Lei Zheng; Xiao-Ming Lv; Bao-Min Zheng; Kathleen H Reilly; Xiao-Yan Yan; Ping Ji; Yang-Feng Wu; Jian-Guo Zhang
Journal:  BMC Cancer       Date:  2016-03-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.